Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients.

advanced non-small cell lung cancer molecular diagnostics mutations nCounter next-generation sequencing

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
03 Nov 2020
Historique:
received: 07 10 2020
revised: 30 10 2020
accepted: 02 11 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 7 11 2020
Statut: epublish

Résumé

Targeted therapies are a new paradigm in lung cancer management. Next-generation sequencing (NGS) techniques have allowed for simultaneous testing of several genes in a rapid and efficient manner; however, there are other molecular diagnostic tools such as the nCounter

Identifiants

pubmed: 33153192
pii: diagnostics10110902
doi: 10.3390/diagnostics10110902
pmc: PMC7693424
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Transl Oncol. 2019 Jan;21(1):3-17
pubmed: 30446985
J Clin Oncol. 2018 Aug 1;36(22):2244-2250
pubmed: 29864379
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
N Engl J Med. 2020 Sep 3;383(10):931-943
pubmed: 32469185
BMC Cancer. 2015 Jan 31;15:26
pubmed: 25637035
Lancet. 2017 Mar 4;389(10072):917-929
pubmed: 28126333
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
N Engl J Med. 2020 Aug 27;383(9):813-824
pubmed: 32846060
Thorax. 2016 Feb;71(2):177-84
pubmed: 26530085
Lancet Oncol. 2020 Feb;21(2):261-270
pubmed: 31838015
Ann Oncol. 2011 Dec;22(12):2616-2624
pubmed: 22071650
J Thorac Oncol. 2015 May;10(5):768-777
pubmed: 25738220
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
J Natl Compr Canc Netw. 2018 Jul;16(7):807-821
pubmed: 30006423
Cancers (Basel). 2020 Apr 30;12(5):
pubmed: 32365867
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Clin Cancer Res. 2010 Oct 15;16(20):4938-45
pubmed: 20926401
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Eur J Cancer. 2020 Jan;125:49-57
pubmed: 31838405
Signal Transduct Target Ther. 2019 Dec 17;4:61
pubmed: 31871778
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Nat Rev Dis Primers. 2015 May 21;1:15009
pubmed: 27188576
Lancet. 2016 Apr 2;387(10026):1415-1426
pubmed: 26777916
JAMA. 2017 May 9;317(18):1844-1853
pubmed: 28492898
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
N Engl J Med. 2014 Dec 4;371(23):2167-77
pubmed: 25470694
Clin Chem. 2017 Mar;63(3):751-760
pubmed: 28073897
J Clin Oncol. 2017 Aug 1;35(22):2490-2498
pubmed: 28475456
J Thorac Oncol. 2011 Mar;6(3):451-8
pubmed: 21266922
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Ann Oncol. 2017 Dec 01;28(12):3028-3036
pubmed: 29045535
J Clin Oncol. 2019 Jun 1;37(16):1370-1379
pubmed: 30892989
ESMO Open. 2020 Apr;5(2):
pubmed: 32312757
Lancet. 2017 Jul 1;390(10089):29-39
pubmed: 28501140
BMC Clin Pathol. 2015 Nov 18;15:20
pubmed: 26587011
Lancet Oncol. 2017 Oct;18(10):1307-1316
pubmed: 28919011

Auteurs

Elba Marin (E)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Roxana Reyes (R)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Ainara Arcocha (A)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Nuria Viñolas (N)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Laura Mezquita (L)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Elena Gonzalvo (E)

Division of Pathology, Hospital Clínic, 08036 Barcelona, Spain.

Karmele Saez de Gordoa (K)

Division of Pathology, Hospital Clínic, 08036 Barcelona, Spain.

Pedro Jares (P)

Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.
Division of Pathology, Hospital Clínic, 08036 Barcelona, Spain.
Molecular Biology Core Facility, Hospital Clínic, 08036 Barcelona, Spain.

Noemi Reguart (N)

Division of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.
Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.

Cristina Teixido (C)

Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain.
Unitat funcional de Tumors Toràcics, Hospital Clínic, 08036 Barcelona, Spain.
Division of Pathology, Hospital Clínic, 08036 Barcelona, Spain.

Classifications MeSH